Literature DB >> 8495424

Base transitions are the most frequent genetic changes at P53 in gastric cancer.

B Renault1, M van den Broek, R Fodde, J Wijnen, N S Pellegata, D Amadori, P M Khan, G N Ranzani.   

Abstract

We searched for P53 mutations in gastric carcinoma by analyzing tumor DNAs from 29 patients. We detected 13 different somatic mutations in 15 patients (52%) and a biallelic polymorphism in exon 6 (5 heterozygous subjects). The somatic mutations were mainly localized in the sequences corresponding to the highly conserved domains of the protein. Twelve samples showed a single base change: 11 missense and 1 nonsense mutations. Three samples showed deletions leading to a frame shift, to the in-frame loss of 2 amino acids, and to the deletion of a splicing site. All point mutations, except one, were transitions, and 91% of them were G:C-->A:T changes. We previously analyzed this panel of tumors for allelic loss at the 17p13 chromosomal region, where the P53 gene had previously been located: the results showed an increasing incidence of allelic loss in late-stage tumors. On the contrary, in the present study no trend between P53 mutations and tumor stages was found. This observation indicates that mutation events precede allelic loss in gastric cancer. Half (54%) of the mutations occurred in samples without allelic loss, suggesting that specific mutated alleles, acting in a dominant negative fashion, can alter in vivo the P53 protein function.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8495424

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  31 in total

1.  Bcl-2 expression and allelic loss of the p53 gene in gastric carcinomas.

Authors:  M Saegusa; Y Takano; Y Kamata; J Okayasu
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

2.  Clonality analysis of neuroendocrine cells in gastric adenocarcinoma.

Authors:  Ling-Ling Wang; Gen-You Yao; Zhong-Sheng Zhao; Xiao-Li Wei; Ru-Jun Xu
Journal:  World J Gastroenterol       Date:  2013-08-28       Impact factor: 5.742

3.  Analysis of chromosome 17p13 (p53 locus) alterations in gastric carcinoma cells by dual-color fluorescence in situ hybridization.

Authors:  M Kobayashi; A Kawashima; M Mai; A Ooi
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

4.  p53 abnormalities in adenocarcinoma of the gastric cardia and antrum.

Authors:  J F Fléjou; V Gratio; F Muzeau; R Hamelin
Journal:  Mol Pathol       Date:  1999-10

5.  TP53 gene mutations in gastric carcinoma detected by polymerase chain reaction/single-strand conformation polymorphism analysis of archival material.

Authors:  E D'Andrea; R Baffa; C Menin; M Montagna; M Rugge; L Chieco-Bianchi
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

6.  p53 alteration in gastric precancerous lesions.

Authors:  Y H Shiao; M Rugge; P Correa; H P Lehmann; W D Scheer
Journal:  Am J Pathol       Date:  1994-03       Impact factor: 4.307

7.  p53 mutations in gastric and colorectal cancers in Texas Hispanics versus Anglos.

Authors:  B G Schneider; S G Hilsenbeck; C H Hensel; V Pekkel; C H Shelton; H A Rodríguez-Martínez; M E Gutiérrez-Díaz; D R Pulitzer; D C Allred
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

8.  Correlation of p53 over-expression and alteration in p53 gene detected by polymerase chain reaction-single strand conformation polymorphism in adenocarcinoma of gastric cancer patients from India.

Authors:  Sajjad Karim; Arif Ali
Journal:  World J Gastroenterol       Date:  2009-03-21       Impact factor: 5.742

9.  Loss of heterozygosity and K-ras gene mutations in gastric cancer.

Authors:  G N Ranzani; B Renault; N S Pellegata; P Fattorini; E Magni; F Bacci; D Amadori
Journal:  Hum Genet       Date:  1993-10-01       Impact factor: 4.132

10.  Plasma MIC-1 correlates with systemic inflammation but is not an independent determinant of nutritional status or survival in oesophago-gastric cancer.

Authors:  R J E Skipworth; D A C Deans; B H L Tan; K Sangster; S Paterson-Brown; D A Brown; M Hunter; S N Breit; J A Ross; K C H Fearon
Journal:  Br J Cancer       Date:  2010-01-26       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.